
Adolescent Suicidal Thoughts Decline for First Time in Years, Federal Survey Finds
2025 NSDUH data shows first decline in adolescent suicidal ideation since 2021, but experts urge caution as rates remain historically high.
16 articles found
Browse Rainier Rehab's editorial coverage of Data reports. Our writers track federal and state policy, peer-reviewed research, treatment innovations, and frontline reporting from the addiction recovery field. Each article in this collection cites primary sources — government datasets (SAMHSA, NIH, CDC), Medicaid and Medicare bulletins, JAMA and Lancet studies, and on-the-record statements from clinicians, regulators, and people in recovery — so readers can verify claims and dig deeper.
We update this tag whenever new data reports reporting publishes. If you're a researcher, journalist, or family member trying to make sense of substance use disorder treatment, this is the working archive. For a directory of accredited treatment facilities, visit our facilities directory; to compare modalities, see our treatments overview and levels of care guide.

2025 NSDUH data shows first decline in adolescent suicidal ideation since 2021, but experts urge caution as rates remain historically high.

New CDC provisional data reveals fentanyl-related fatalities have dropped by more than half from their peak, with total overdose deaths down 14% in 2025.

DEA's inaugural Fentanyl Free America Summit concludes with enforcement results showing over 4 million pills and 1,158 kilograms of fentanyl powder seized in six weeks.

A new study reveals that over 93% of rural US counties have no Medicare-enrolled opioid treatment program, creating dangerous barriers to methadone access for 9.3 million Medicare enrollees.

New research reveals that rising temperatures significantly increase overdose mortality, with each degree of heat index elevation contributing to approximately 150 excess deaths annually.

Landmark Canadian study shows take-home naloxone kits prevented nearly 4 in 5 fatal overdoses from 2019-2024, offering evidence for harm reduction strategies

CDC provisional data shows 69,147 predicted overdose deaths for the 12 months ending January 2026, a 13.2% decline as naloxone access and treatment expansion show measurable impact.

For the first time since 2013, Massachusetts recorded fewer than 1,000 opioid-related overdose deaths in 2025, marking a nearly 60% decline from the 2022 peak.

Baltimore County unveils a transparent online dashboard allowing residents to monitor how opioid settlement funds are being used to combat the addiction crisis.

Landmark UC San Diego study reveals first decline in all four waves of overdose epidemic, driven by falling fentanyl deaths, while stimulant-related fatalities continue rising.

Law enforcement reports fentanyl increasingly combined with xylazine, medetomidine, nitazenes and cychlorphine—substances that resist naloxone reversal.

CDC study reveals gabapentin detection in overdose deaths increased significantly, with 85-90% of cases also involving opioids

Kentucky reports lowest overdose death toll since 2014, with 1,101 fatalities representing 50% decrease from 2021 peak

CDC MMWR report reveals 44 cases of invasive Haemophilus influenzae type b disease in Alaska, Oregon, and Washington, predominantly affecting adults using substances or experiencing homelessness.

CDC data shows historic 37% decline in drug deaths since 2023 peak, but medetomidine, cychlorphine, and nitazenes threaten progress.

Federal health officials alert providers to medetomidine, a potent animal sedative spreading through the illegal opioid supply, causing naloxone-resistant overdoses and life-threatening withdrawal.